Genes, Stress and Psychopathology

基因、压力和精神病理学

基本信息

  • 批准号:
    7568868
  • 负责人:
  • 金额:
    $ 47.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-01-25 至 2011-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Depression is the leading cause of disease-related disability in women. Studies have shown that the lifetime prevalence of a major depressive disorder in women (21,3%) is almost twice that in men (12.7%). An altered stress response resulting in intermittent aberrant cortisol exposure often accompanies depression and anxiety disorders. Growing evidence indicates that this phenotype may precede the manifestations of affective illness and persist even when the mental disorder has been in long term remission. It has been proposed that aberrant cortisol dynamics is an intermediate phenotype placing individuals at increased risk for the development of certain psychiatric disorders. In aim 1, we are proposing to perform a quantitative trait study testing for an association of a specific phenotype with a set of 15 candidate genes and functional polymorphisms in a population of healthy women. We will determine Which functional polymorphisms and gene haplotypes predict the magnitude of cortisol responses to psychological stress. We selected ~20 SNPs per gene that had minor allelic frequencies of >10%, and based on data from HAPMAP (International HAPMAP consortium, 2003), captured the common variation within the haplotype blocks across each gene. In aim 2, we propose to examine the relationship of cortisol responses to personality traits, with the hypothesis that those personalities most closely related to depression and anxiety disorders will be most correlated with heightened stress response. This hypothesis is supported by our preliminary data showing a significant correlation between cortisol responses to the psychological stress test and the personality dimensions of Neuroticism. There is growing interest in neuroticism as a risk factor for depression. In aim 3, will take the associated genetic variants discovered in aim 1 and test them on a separate, already existing sample, using the cortisol-correlated personality traits from specific aim 2. The existing sample, the Epidemiologic Catchment Area Genetics of Personality Sample contains 350 women who have NEO and TCI scores previously obtained, and DNA samples available. Results from these studies will inform the mental health field as well as the broader disciplines of neuroscience and metabolism.
描述(由申请人提供):抑郁症是女性疾病相关残疾的主要原因。研究表明,女性重度抑郁症的终生患病率(21.3%)几乎是男性(12.7%)的两倍。导致间歇性异常皮质醇暴露的应激反应改变通常伴随着抑郁症和焦虑症。越来越多的证据表明,这种表型可能先于情感性疾病的表现,甚至在精神障碍长期缓解时也会持续存在。有人提出,异常的皮质醇动力学是一种中间表型,使个体患某些精神疾病的风险增加。在目标1中,我们建议在健康女性人群中进行一项数量性状研究,以检测特定表型与一组15个候选基因和功能多态性之间的关联。我们将确定哪些功能多态性和基因单倍型预测皮质醇对心理压力的反应程度。我们在每个基因中选择了约20个小等位基因频率为10%的snp,并基于HAPMAP (International HAPMAP consortium, 2003)的数据,捕获了每个基因的单倍型块内的共同变异。在目标2中,我们建议研究皮质醇反应与人格特征的关系,假设那些与抑郁和焦虑障碍最密切相关的人格将与高度的压力反应最相关。我们的初步数据显示,皮质醇对心理压力测试的反应与神经质的人格维度之间存在显著的相关性,这一假设得到了支持。人们对神经质作为抑郁症的风险因素的兴趣越来越大。在目标3中,将采用目标1中发现的相关遗传变异,并使用特定目标2中与皮质醇相关的人格特征,在一个单独的、已经存在的样本上进行测试。现有的样本,即流行病学集水区人格遗传学样本,包含350名女性,她们之前获得了NEO和TCI分数,并提供了DNA样本。这些研究的结果将为心理健康领域以及更广泛的神经科学和代谢学科提供信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY S WAND其他文献

GARY S WAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY S WAND', 18)}}的其他基金

Laboratory studies on oxytocin for treatment of alcohol dependence
催产素治疗酒精依赖的实验室研究
  • 批准号:
    8619250
  • 财政年份:
    2014
  • 资助金额:
    $ 47.01万
  • 项目类别:
Laboratory studies on oxytocin for treatment of alcohol dependence
催产素治疗酒精依赖的实验室研究
  • 批准号:
    8892009
  • 财政年份:
    2014
  • 资助金额:
    $ 47.01万
  • 项目类别:
Neuroendocrine Investigators and Mentoring in the field of Alcohol Research
酒精研究领域的神经内分泌研究人员和指导
  • 批准号:
    8323376
  • 财政年份:
    2011
  • 资助金额:
    $ 47.01万
  • 项目类别:
Neuroendocrine Investigators and Mentoring in the field of Alcohol Research
酒精研究领域的神经内分泌研究人员和指导
  • 批准号:
    8902743
  • 财政年份:
    2011
  • 资助金额:
    $ 47.01万
  • 项目类别:
Neuroendocrine Investigators and Mentoring in the field of Alcohol Research
酒精研究领域的神经内分泌研究人员和指导
  • 批准号:
    8730059
  • 财政年份:
    2011
  • 资助金额:
    $ 47.01万
  • 项目类别:
Neuroendocrine Investigators and Mentoring in the field of Alcohol Research
酒精研究领域的神经内分泌研究人员和指导
  • 批准号:
    8092057
  • 财政年份:
    2011
  • 资助金额:
    $ 47.01万
  • 项目类别:
Neuroendocrine Investigators and Mentoring in the field of Alcohol Research
酒精研究领域的神经内分泌研究人员和指导
  • 批准号:
    8530115
  • 财政年份:
    2011
  • 资助金额:
    $ 47.01万
  • 项目类别:
Genes, Stress and Psychopathology
基因、压力和精神病理学
  • 批准号:
    7211002
  • 财政年份:
    2007
  • 资助金额:
    $ 47.01万
  • 项目类别:
Genes, Stress and Psychopathology
基因、压力和精神病理学
  • 批准号:
    8025966
  • 财政年份:
    2007
  • 资助金额:
    $ 47.01万
  • 项目类别:
Genes, Stress and Psychopathology
基因、压力和精神病理学
  • 批准号:
    7743988
  • 财政年份:
    2007
  • 资助金额:
    $ 47.01万
  • 项目类别:

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 47.01万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 47.01万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 47.01万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 47.01万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 47.01万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    $ 47.01万
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    $ 47.01万
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    $ 47.01万
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    $ 47.01万
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    $ 47.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了